Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
